FDA Inspection
Carter BloodCare at KellerCarter BloodCare at Keller – FDA Inspection, Jun 24, 2009
Record Details
This FDA Inspection record concerns Carter BloodCare at Keller, with an inspection on June 24, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Carter BloodCare at Keller
- Inspection Date
- June 24, 2009
- Product Type
- Biologics
View Company Profile
ID · ad6b0a75-cd44-4135-9a5c-2365716e6b40
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 594217
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carter BloodCare at Keller
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 26, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 24, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 13, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 21, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 11, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare at Keller
- FDA Inspection 1242651 - 2024-06-26
- FDA Inspection 1079838 - 2019-01-24
- FDA Inspection 1015107 - 2017-06-13
- FDA Inspection 910813 - 2015-01-21
- FDA Inspection 835678 - 2013-06-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.